Powell Dina H. 4

4 · Meta Platforms, Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 25, 2026

Meta (META) President Dina Powell Receives Stock Option Awards

What Happened

Dina H. Powell, President and Vice Chairman of Meta Platforms, received seven option awards (derivative grants) on March 20, 2026 covering a total of 245,202 shares. Each grant shows an acquisition price of $0 (these are option awards, not open‑market purchases or sales).

Key Details

Transaction date: 2026-03-20 (Form 4 filed 2026-03-24).
Total options granted: 245,202 shares across seven tranches (4,803; 6,775; 11,003; 36,578; 58,310; 93,518; 34,215). Reported acquisition price: $0 (award).
Transaction code: A = Award/Grant.
Shares owned after the transaction: not specified in the provided excerpt of the filing.
Vesting notes (from filing footnotes):
- Price-vesting period runs through Feb 14, 2028: any tranche vests in full if Meta’s Class A share price meets/exceeds the tranche’s exercise price at any time during that period, subject to Powell’s continued service.
- Any tranches that do not vest during that period will vest post-period: 6/16 of the total on Feb 15, 2028, then 1/16 quarterly thereafter, with the final 1/16 vesting on Aug 15, 2030, subject to continued service.
Exercise prices for each tranche were referenced in the filing but are not included in the excerpt provided here.

Context

These are equity compensation awards (stock options) tied to price and service conditions, not cash purchases or sales. Such grants are common for executive compensation and do not by themselves indicate immediate trading intent.
There is no indication in the excerpt that any options were exercised or that shares were sold immediately.

Form 4

Period: 2026-03-20

President and Vice Chairman

Transactions

Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+4,803→ 4,803 total
Exercise: $1116.08Exp: 2031-03-19→ Class A Common Stock (4,803 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+6,775→ 6,775 total
Exercise: $1393.87Exp: 2031-03-19→ Class A Common Stock (6,775 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+11,003→ 11,003 total
Exercise: $1724.41Exp: 2031-03-19→ Class A Common Stock (11,003 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+36,578→ 36,578 total
Exercise: $2114.87Exp: 2031-03-19→ Class A Common Stock (36,578 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+58,310→ 58,310 total
Exercise: $2573.06Exp: 2031-03-19→ Class A Common Stock (58,310 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+93,518→ 93,518 total
Exercise: $3107.44Exp: 2031-03-19→ Class A Common Stock (93,518 underlying)
Award
Stock Options (right to buy)
[F1][F2]
2026-03-20+34,215→ 34,215 total
Exercise: $3727.12Exp: 2031-03-19→ Class A Common Stock (34,215 underlying)

Footnotes (2)

[F1]The stock options to acquire Issuer's Class A Common Stock (the "Options") vest and become exercisable as follows: from the date of grant up to and including February 14, 2028 (the "Price Vesting Period"), if the per share price of the Issuer's Class A Common Stock on NASDAQ meets or exceeds the per share exercise price relating to the applicable tranche of Options set forth above at any time during the Price Vesting Period, then each such tranche of Options will fully vest on such date, subject to the Reporting Person's continued service through each such date.
[F2]Following the Price Vesting Period, any tranches of Options that did not vest during the Price Vesting Period will only vest with respect to 6/16ths of the total Options on February 15, 2028, and then 1/16th of the total Options quarterly thereafter, with the final 1/16th of the total Options vesting on August 15, 2030, with the vesting occurring equally across each tranche, subject to the Reporting Person's continued service through each such date.

Signature

/s/ Erin Guldiken, attorney-in-fact for Dina H. Powell|2026-03-24

1 file